Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Mol Cancer Ther. 2016 Dec 21;16(3):440–452. doi: 10.1158/1535-7163.MCT-16-0285

Figure 4. CelePlum-777 treatment synergistically inhibited melanoma tumor growth.

Figure 4

Vascularized xenografts of UACC 903 (A and B) or 1205 Lu (C, D, E, and F) melanoma cells were treated intravenously on alternate days with liposomes containing single agents (Celecoxib 15 mg/Kg or Plumbagin 0.75 or 1.5 mg/Kg body weight), or CelePlum-777 (Celecoxib 15 mg/Kg + Plumbagin 0.75 or 1.5 mg/Kg body weight) for 3 to 4 weeks. The line graph indicates tumor volume (mm3) and inset body weight. Data represent experiments of 3 mice per group, containing two tumors per mouse; bars, S.E.M.